A circulating tumor cell (CTC) count is an established prognostic factor in some malignancies such as metastatic breast cancer. However, the value of CTC in diagnosis and outcome prediction of metastatic nasopharyngeal carcinoma (mNPC) patients is not unknown. Through the observational prospective clinical trial, sensitivity, specificity, positive and negative predictive values of CTC in diagnosis of mNPC patients will be gained. Further, the value of CTC in outcome prediction of mNPC patients will be uncovered.
Study Type
OBSERVATIONAL
Enrollment
166
Overall survival rate
Time frame: 3 years
The proportion of positives that are correctly identified as such
number of true positives divided by (number of true positives plus number of false negatives)
Time frame: 3 years
The proportion of negatives that are correctly identified as such
number of true negatives divided by (number of true negatives plus number of false positives)
Time frame: 3 years
The proportions of positive results in statistics and diagnostic tests that are true positive results.
number of true positives divided by number of positive calls
Time frame: 3 years
The proportions of negative results in statistics and diagnostic tests that are true negative results.
number of true negatives divided by number of negative calls
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.